Can Buying NKGen Biotech Inc (NASDAQ: NKGN) Still Be Worthwhile?

NKGen Biotech Inc (NASDAQ:NKGN) does about 1.33M shares in volume on a normal day but saw 750324 shares change hands in the recent trading day. The company now has a market cap of 17.30M USD. Its current market price is $0.49, marking an increase of 10.71% compared to the previous close of $0.44. The 52 week high reached by this stock is $4.06 whilst the lowest price level in 52 weeks is $0.20.

NKGen Biotech Inc (NKGN) has a 20-day trading average at $0.3226 and the current price is -88.00% off the 52-week high compared with 140.38% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.3429 and its 200-day simple moving average is $1.0244. If we look at the stock’s price movements over the week, volatility stands at 16.02%, which decreases to 15.13% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 66.40 to suggest the stock is neutral.

The current price level is 50.95%, 42.02%, and -52.46% away from its SMA20, SMA50, and SMA200 respectively, with the NKGN price moving below the 50-day SMA on current market day. NKGen Biotech Inc (NKGN) stock is up 34.01% over the week and 82.26% over the past month. Its price is -82.29% year-to-date and -85.57% over the past year.

The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year.

The company has a return on equity of -118.66%. The beta has a value of 0.75.